skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: autor: Amellal, Nadia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

Bonner, James A ; Harari, Paul M ; Giralt, Jordi ; Azarnia, Nozar ; Shin, Dong M ; Cohen, Roger B ; Jones, Christopher U ; Sur, Ranjan ; Raben, David ; Jassem, Jacek ; Ove, Roger ; Kies, Merrill S ; Baselga, Jose ; Youssoufian, Hagop ; Amellal, Nadia ; Rowinsky, Eric K ; Ang, K. Kian

The New England journal of medicine, 2006-02, Vol.354 (6), p.567-578 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Vermorken, Jan B ; Mesia, Ricard ; Rivera, Fernando ; Remenar, Eva ; Kawecki, Andrzej ; Rottey, Sylvie ; Erfan, Jozsef ; Zabolotnyy, Dmytro ; Kienzer, Heinz-Roland ; Cupissol, Didier ; Peyrade, Frederic ; Benasso, Marco ; Vynnychenko, Ihor ; De Raucourt, Dominique ; Bokemeyer, Carsten ; Schueler, Armin ; Amellal, Nadia ; Hitt, Ricardo

The New England journal of medicine, 2008-09, Vol.359 (11), p.1116-1127 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

VERMORKEN, Jan B ; TRIGO, José ; HITT, Ricardo ; KORALEWSKI, Piotr ; DIAZ-RUBIO, Eduardo ; ROLLAND, Frédéric ; KNECHT, Rainald ; AMELLAL, Nadia ; SCHUELER, Armin ; BASELGA, José

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2171-2177 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
4
First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design
First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design

André, Thierry ; Saunders, Mark ; Kanehisa, Akira ; Gandossi, Eric ; Fougeray, Ronan ; Amellal, Nadia Causse ; Falcone, Alfredo

Future oncology (London, England), 2020-02, Vol.16 (4), p.21-29 [Periódico revisado por pares]

England: Future Medicine Ltd

Texto completo disponível

Citações Citado por
5
Impact of colorectal liver metastases (CRLM) in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial
Impact of colorectal liver metastases (CRLM) in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of colorectal liver metastases (CRLM) in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial

Tabernero, Josep ; Prager, Gerald W. ; Taieb, Julien ; Calleja, Elizabeth Martine ; Liu, Mei ; Amellal, Nadia ; Fakih, Marwan

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3584-3584 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
6
Relationship between fluoropyrimidine (FPD) exposure and outcomes in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial
Relationship between fluoropyrimidine (FPD) exposure and outcomes in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relationship between fluoropyrimidine (FPD) exposure and outcomes in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial

Fakih, Marwan ; Prager, Gerald W. ; Taieb, Julien ; Calleja, Elizabeth Martine ; Liu, Mei ; Amellal, Nadia ; Tabernero, Josep

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.114-114 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
7
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design

Tabernero, Josep ; Taieb, Julien ; Prager, Gerald W ; Ciardiello, Fortunato ; Fakih, Marwan ; Leger, Catherine ; Fougeray, Ronan ; Amellal, Nadia ; Van Cutsem, Eric

Future oncology (London, England), 2021-06, Vol.17 (16), p.1977-1985 [Periódico revisado por pares]

England: Future Medicine Ltd

Texto completo disponível

Citações Citado por
8
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

Prager, Gerald W. ; Taieb, Julien ; Fakih, Marwan ; Ciardiello, Fortunato ; Van Cutsem, Eric ; Elez, Elena ; Cruz, Felipe M. ; Wyrwicz, Lucjan ; Stroyakovskiy, Daniil ; Pápai, Zsuzsanna ; Poureau, Pierre-Guillaume ; Liposits, Gabor ; Cremolini, Chiara ; Bondarenko, Igor ; Modest, Dominik P. ; Benhadji, Karim A. ; Amellal, Nadia ; Leger, Catherine ; Vidot, Loïck ; Tabernero, Josep

The New England journal of medicine, 2023-05, Vol.388 (18), p.1657-1667 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS
Material Type:
Artigo 		Adicionar ao Meu Espaço

Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS

Tabernero, Josep ; Alsina, Maria ; Shitara, Kohei ; Doi, Toshihiko ; Dvorkin, Mikhail ; Mansoor, Wasat ; Arkenau, Hendrik-Tobias ; Prokharau, Aliaksandr ; Ghidini, Michele ; Faustino, Catia ; Gorbunova, Vera ; Zhavrid, Edvard ; Nishikawa, Kazuhiro ; Ando, Takayuki ; Yalçın, Şuayib ; Van Cutsem, Eric ; Sabater, Javier ; Skanji, Donia ; Leger, Catherine ; Amellal, Nadia ; Ilson, David H.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-07, Vol.23 (4), p.689-698 [Periódico revisado por pares]

Singapore: Springer Singapore

Texto completo disponível

Citações Citado por
10
Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

CHAN, Anthony T. C ; HSU, Mow-Ming ; MUESER, Matthias ; AMELLAL, Nadia ; XIAO LIN ; CHANG, Alex Y ; GOH, Boon C ; HUI, Edwin P ; LIU, Tsang-Wu ; MILLWARD, Michael J ; HONG, Ruey-Long ; WHANG-PENG, Jacqueline ; MA, Brigette B. Y ; TO, Ka F

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3568-3576 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (34)
  2. Revistas revisadas por pares (42)

Data de Publicação 

De até
Refinar
  1. Antes de2007  (5)
  2. 2007Até2012  (6)
  3. 2013Até2017  (11)
  4. 2018Até2021  (12)
  5. Após 2021  (11)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.